The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia.

5-azanucleosides decitabine acute myeloid leukemia decitabine/cedazuridine epigenetics hypomethylating agents hypomethylation novel combination therapy for AML oral decitabine oral therapy for AML therapy for elderly and unfit patients with AML

Journal

Therapeutic advances in hematology
ISSN: 2040-6207
Titre abrégé: Ther Adv Hematol
Pays: England
ID NLM: 101549589

Informations de publication

Date de publication:
2023
Historique:
received: 08 06 2023
accepted: 15 09 2023
medline: 19 10 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: epublish

Résumé

Decitabine, a member of the 5-azanucleosides, has a dose-dependent mechanism of action

Identifiants

pubmed: 37854355
doi: 10.1177/20406207231205429
pii: 10.1177_20406207231205429
pmc: PMC10580721
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

20406207231205429

Informations de copyright

© The Author(s), 2023.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest.

Références

Curr Treat Options Oncol. 2021 Mar 20;22(5):39
pubmed: 33743079
Exp Cell Res. 1972 Oct;74(2):383-90
pubmed: 4673149
Leukemia. 1997 Mar;11 Suppl 1:S24-7
pubmed: 9130688
Leuk Res. 1981;5(6):453-62
pubmed: 6173545
Lancet Haematol. 2020 Oct;7(10):e724-e736
pubmed: 32896301
Cancer Chemother Rep. 1966 May;50(4):219-44
pubmed: 4957125
Adv Cytopharmacol. 1971 May;1:13-24
pubmed: 5163242
N Engl J Med. 1982 Dec 9;307(24):1469-75
pubmed: 6183586
Cancer. 1976 Feb;37(2 Suppl):1014-23
pubmed: 766951
Proc Natl Acad Sci U S A. 1982 Feb;79(4):1215-9
pubmed: 6175964
Pharmacol Ther. 1985;30(3):277-86
pubmed: 2433702
Leukemia. 1997 Mar;11 Suppl 1:S28-31
pubmed: 9130689
Science. 1946 Nov 8;104(2706):436-7
pubmed: 17819687
Blood. 1949 Feb;4(2):160-7
pubmed: 18107667
Cytogenet Cell Genet. 1975;14(1):9-25
pubmed: 1093816
Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):6961-5
pubmed: 1871110
Cancer Res. 1977 Jul;37(7 Pt 1):2202-8
pubmed: 67887
Leukemia. 1993 May;7 Suppl 1:30-5
pubmed: 7683354
Drug Chem Toxicol. 1981;4(4):373-81
pubmed: 6178576
Adv Heterocycl Chem. 1963;11:189-251
pubmed: 14087220
Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):e185-e198
pubmed: 34674983
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7473-8
pubmed: 20368434
Biochemistry. 1968 Jan;7(1):280-5
pubmed: 4991479
Science. 1975 Jan 24;187(4173):226-32
pubmed: 1111098
Cancer Res. 1977 Jun;37(6):1934-7
pubmed: 404039
Am J Hematol. 2021 Apr 1;96(4):493-507
pubmed: 33368536
Blood. 1953 Nov;8(11):965-99
pubmed: 13105700
Experientia. 1964 Apr 15;20(4):202-3
pubmed: 5322617
Blood. 2020 Aug 6;136(6):674-683
pubmed: 32285126
Blood Cells Mol Dis. 2013 Feb;50(2):119-30
pubmed: 23154039
Leukemia. 1993 May;7 Suppl 1:36-41
pubmed: 7683355
Br J Cancer. 1991 Jul;64(1):144-8
pubmed: 1713050
Antiviral Res. 2018 Jun;154:66-86
pubmed: 29649496
Biochem Pharmacol. 1965 Oct;14(10):1405-16
pubmed: 4956026
J Clin Oncol. 2010 Feb 1;28(4):556-61
pubmed: 20026803
Leuk Res. 1984;8(2):181-5
pubmed: 6201685
Blood Adv. 2022 Jul 12;6(13):3879-3883
pubmed: 35511730
Lancet Haematol. 2021 Feb;8(2):e122-e134
pubmed: 33347814
Leuk Lymphoma. 2013 Sep;54(9):2003-7
pubmed: 23270581
Nature. 1977 May 26;267(5609):364-6
pubmed: 68440
Br J Haematol. 2023 May;201(3):e25-e29
pubmed: 36951293
Oncogene. 2002 Aug 12;21(35):5483-95
pubmed: 12154409
Blood. 2004 Mar 1;103(5):1635-40
pubmed: 14604977
Blood. 2019 Jan 3;133(1):7-17
pubmed: 30361262
Science. 1947 Dec 19;106(2764):619-21
pubmed: 17831847
J Biol Chem. 1948 Aug;175(1):315-32
pubmed: 18873306
Science. 1989 Apr 7;244(4900):41-7
pubmed: 2649979
J Clin Oncol. 2012 Jul 20;30(21):2670-7
pubmed: 22689805
Cell. 1980 May;20(1):85-93
pubmed: 6156004
Science. 1984 Nov 30;226(4678):1097-9
pubmed: 6093263
N Engl J Med. 1948 Jun 3;238(23):787-93
pubmed: 18860765
Cancer. 2021 Oct 15;127(20):3772-3781
pubmed: 34255353
Leukemia. 1993 May;7 Suppl 1:49-50
pubmed: 7683357
Gesnerus. 1988;45 Pt 1:67-86
pubmed: 3042521
J Biol Chem. 1946 Jul;164:485
pubmed: 20989508
J Clin Oncol. 2000 Mar;18(5):956-62
pubmed: 10694544
Genetics. 1974 Sep;78(1):115-32
pubmed: 4531409
Cancer Res. 1973 Dec;33(12):3239-49
pubmed: 4796800
Blood. 1984 Oct;64(4):922-9
pubmed: 6206904
Nat Med. 2020 Oct;26(10):1549-1556
pubmed: 32747829
Cell Death Differ. 2004 Jul;11 Suppl 1:S28-32
pubmed: 15118765
Lancet Haematol. 2019 Apr;6(4):e194-e203
pubmed: 30926081
Blood. 2000 Oct 1;96(7):2379-84
pubmed: 11001887
N Engl J Med. 2020 Aug 13;383(7):617-629
pubmed: 32786187
Leuk Lymphoma. 2015 Jan;56(1):226-9
pubmed: 24707940

Auteurs

Robert Briski (R)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Guillermo Garcia-Manero (G)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hagop Kantarjian (H)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Farhad Ravandi (F)

The University of Texas MD Anderson Cancer Center, Unit 428, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Classifications MeSH